retatrutide trial news results This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far A new clinical trial from

References 1 AbbasT.FaivreE.HlscherC

O peptdeo insulinotrpico dependente de glicose (GIP) e o peptdeo semelhante ao glucagon-1 (GLP-1) so as duas principais incretinas conhecidas (figura 1)

As tirzepatide has continually outperformed semaglutide in clinical trials, some wonder whether it will prove more effective as a microdosed drug

While body fat often reduces gradually, facial fat pads shrink quickly , especially in the cheeks, temples, and under-eyes

Lumen: Metabolic Insights Lumen isn't GLP-1 specific, but it provides valuable metabolic feedback

The compound remains in Phase 3 clinical trials, with multiple studies expected to report results throughout this year